These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 7293840

  • 1. Hypertension in the elderly. Hypertension seminars at Ostra Hospital, Göteborg, Sweden.
    Amery A, Hansson L, Andrén L, Gudbrandsson T, Sivertsson R, Svensson A.
    Acta Med Scand; 1981; 210(3):221-9. PubMed ID: 7293840
    [Abstract] [Full Text] [Related]

  • 2. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [Abstract] [Full Text] [Related]

  • 5. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S, Lombardo M.
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Hypertension as a function of age].
    Gensini GF, Corradi F.
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [Abstract] [Full Text] [Related]

  • 9. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM, Genès N, Vaur L, Clerson P, Vaïsse B, Bobrie G, Chatellier G.
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [Abstract] [Full Text] [Related]

  • 10. ESH-ESC guidelines for the management of hypertension.
    Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [Abstract] [Full Text] [Related]

  • 11. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H, Risler T, Trenkwalder P.
    Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
    [Abstract] [Full Text] [Related]

  • 13. On-treatment diastolic blood pressure and prognosis in systolic hypertension.
    Fagard RH, Staessen JA, Thijs L, Celis H, Bulpitt CJ, de Leeuw PW, Leonetti G, Tuomilehto J, Yodfat Y.
    Arch Intern Med; 2007 Sep 24; 167(17):1884-91. PubMed ID: 17893310
    [Abstract] [Full Text] [Related]

  • 14. High blood pressure despite treatment: results from a cross-sectional primary healthcare-based study in southern Sweden.
    Hedblad B, Nerbrand C, Ekesbo R, Johansson L, Midlöv P, Brunkstedt I, Svensson P, Gyllerup S, Sträng B, Persson R, Janzon L.
    Scand J Prim Health Care; 2006 Dec 24; 24(4):224-30. PubMed ID: 17118862
    [Abstract] [Full Text] [Related]

  • 15. Use of moxonidine in elderly patients with resistant hypertension.
    Martin U, Hill C, O' Mahony D.
    J Clin Pharm Ther; 2005 Oct 24; 30(5):433-7. PubMed ID: 16164488
    [Abstract] [Full Text] [Related]

  • 16. Impact of blood pressure control on cardiovascular events in 26,512 Japanese hypertensive patients: the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
    Shimamoto K, Fujita T, Ito S, Naritomi H, Ogihara T, Shimada K, Tanaka H, Yoshiike N, J-HEALTH Study Committees.
    Hypertens Res; 2008 Mar 24; 31(3):469-78. PubMed ID: 18497466
    [Abstract] [Full Text] [Related]

  • 17. Blood pressure control in Italy: results of recent surveys on hypertension.
    Volpe M, Tocci G, Trimarco B, Rosei EA, Borghi C, Ambrosioni E, Menotti A, Zanchetti A, Mancia G.
    J Hypertens; 2007 Jul 24; 25(7):1491-8. PubMed ID: 17563573
    [Abstract] [Full Text] [Related]

  • 18. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI, Lasaridis AN, Sarafidis PA, Tziolas IM, Zebekakis PE, Dombros NV, Giannoulis E.
    Clin Exp Hypertens; 2007 Nov 24; 29(8):563-73. PubMed ID: 18058481
    [Abstract] [Full Text] [Related]

  • 19. Compliance to antihypertensive drugs, salt restriction, exercise and control of systemic hypertension in hypertensive patients at Abbottabad.
    Ahmed N, Abdul Khaliq M, Shah SH, Anwar W.
    J Ayub Med Coll Abbottabad; 2008 Nov 24; 20(2):66-9. PubMed ID: 19385461
    [Abstract] [Full Text] [Related]

  • 20. Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?
    Leonetti G, Cuspidi C, Facchini M, Stramba-Badiale M.
    J Hypertens Suppl; 2000 Jul 24; 18(3):S13-20. PubMed ID: 10952083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.